These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6087652)

  • 1. Lack of interference with creatinine assays by four cephalosporin-like antibiotics.
    Kroll MH; Koch TR; Drusano GL; Warren JW
    Am J Clin Pathol; 1984 Aug; 82(2):214-6. PubMed ID: 6087652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cephalosporin antibiotic agents--III. Third-generation cephalosporins.
    Marsh TD
    Infect Control; 1985 Feb; 6(2):78-83. PubMed ID: 3882594
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of bacterial resistance to the third generation cephalosporins and their clinical use.
    Kolár M; Látal T; Hájek V
    J Chemother; 1999 Aug; 11(4):260-5. PubMed ID: 10465127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of selected second- and third-generation cephalosporins with creatinine determination.
    Guay DR; Meatherall RC; Macaulay PA
    Am J Hosp Pharm; 1983 Mar; 40(3):435-8. PubMed ID: 6846351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
    Pulverer G; Peters G
    Med Welt; 1982 Apr; 33(17):642-4. PubMed ID: 6285119
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
    Neu HC; Labthavikul P
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():101-6. PubMed ID: 6281229
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
    Livermore DM; Williams RJ; Williams JD
    J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of interference of five new beta-lactam antibiotics with serum creatinine determination.
    LeBel M; Paone RP; Lewis GP
    Drug Intell Clin Pharm; 1983 Dec; 17(12):908-10. PubMed ID: 6317326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of BMY-28142, a new cephalosporin.
    Norden CW; Neiderriter K
    Chemotherapy; 1987; 33(1):15-7. PubMed ID: 3103990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
    Rodríguez JR; Hernández NI; Ramírez-Ronda CH; Nevárez M
    Bol Asoc Med P R; 1985 Jun; 77(6):242-4. PubMed ID: 3931655
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference by the new antibiotic cefpirome and other cephalosporins in clinical laboratory tests, with special regard to the "Jaffé" reaction.
    Grötsch H; Hajdu P
    J Clin Chem Clin Biochem; 1987 Jan; 25(1):49-52. PubMed ID: 3559483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
    McNamee W; Drusano GL; Tatem BA; Standiford HC
    J Antimicrob Chemother; 1984 Nov; 14(5):491-7. PubMed ID: 6096348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
    Carlone NA; Cuffini AM; Forno-Pizzoglio M; Aragno M
    G Batteriol Virol Immunol; 1983; 76(7-12):246-56. PubMed ID: 6099297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
    Norris SM; Guenthner SH; Wenzel RP
    J Antimicrob Chemother; 1985 Aug; 16(2):183-8. PubMed ID: 3934124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of four new cephalosporins: moxalactam, cefotaxime, cefoperazone and ceftazidime in neonates.
    Bégué P; Safran C; Quiniou F; Lasfargues G; Quinet B
    Dev Pharmacol Ther; 1984; 7 Suppl 1():105-8. PubMed ID: 6097425
    [No Abstract]   [Full Text] [Related]  

  • 20. Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
    Woolfrey BF; Fox JM; Quall CO
    J Antimicrob Chemother; 1981 Sep; 8(3):205-11. PubMed ID: 6270052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.